Should investors be concerned about Jumia Technologies Ag ADR (JMIA)?

While Jumia Technologies Ag ADR has underperformed by -1.62%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, JMIA rose by 11.52%, with highs and lows ranging from $15.04 to $1.60, whereas the simple moving average jumped by 18.08% in the last 200 days.

On November 13, 2024, RBC Capital Mkts started tracking Jumia Technologies Ag ADR (NYSE: JMIA) recommending Sector Perform. A report published by The Benchmark Company on July 09, 2024, Initiated its previous ‘Buy’ rating for JMIA. Morgan Stanley also Upgraded JMIA shares as ‘Equal-Weight’, setting a target price of $3.60 on the company’s shares in a report dated January 03, 2024. Stifel May 14, 2020d its ‘Buy’ rating to ‘Hold’ for JMIA, as published in its report on May 14, 2020. RBC Capital Mkts also rated the stock as ‘Outperform’.

Analysis of Jumia Technologies Ag ADR (JMIA)

Further, the quarter-over-quarter decrease in sales is -25.84%, showing a negative trend in the upcoming months.

There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Jumia Technologies Ag ADR’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of -134.38% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.46, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

As an indicator of volatility for any stock, average volume can also be very valuable, and JMIA is recording an average volume of 3.25M. Furthermore, long-term investors anticipate a median target price of $4.75, showing growth from the present price of $4.26, which can serve as yet another indication of whether JMIA is worth investing in or should be passed over.

How Do You Analyze Jumia Technologies Ag ADR Shares?

Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.35%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 11.36% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

Hot this week

Can Upstart Holdings Inc (UPST) meet market expectations this quarter?

Upstart Holdings Inc (UPST)'s stock has witnessed a price...

CHPT’s earnings forecast for the current quarter

Currently, ChargePoint Holdings Inc's (CHPT) stock is trading at...

Breaking down RDW’s current quarter earnings estimates

In the current trading session, Redwire Corporation's (RDW) stock...

Experts predict Lobo Ev Technologies Ltd’s (LOBO) current quarter earnings growth rate

Lobo Ev Technologies Ltd (LOBO)'s stock is trading at...

Analyzing BORR’s current quarter earnings projections

Borr Drilling Ltd (BORR)'s stock has witnessed a price...

Topics

Can Upstart Holdings Inc (UPST) meet market expectations this quarter?

Upstart Holdings Inc (UPST)'s stock has witnessed a price...

CHPT’s earnings forecast for the current quarter

Currently, ChargePoint Holdings Inc's (CHPT) stock is trading at...

Breaking down RDW’s current quarter earnings estimates

In the current trading session, Redwire Corporation's (RDW) stock...

Analyzing BORR’s current quarter earnings projections

Borr Drilling Ltd (BORR)'s stock has witnessed a price...

Will RxSight Inc (RXST) meet earnings estimates this quarter?

Currently, RxSight Inc's (RXST) stock is trading at $7.3,...

A look at LAES’s current quarter earnings estimates

In the current trading session, SEALSQ Corp's (LAES) stock...

How analysts predict BioXcel Therapeutics Inc (BTAI) will perform this quarter?

BioXcel Therapeutics Inc (BTAI)'s stock is trading at $2.16...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.